Study S001304
A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass
Registration
Registered primary outcomes
- Pancreatic 68Ga-exendin uptake [Change from time of inclusion to 12 months into treatment]
Linked records (0)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
No records link to this registration yet.